Decipher Labs Ltd vs Krebs Biochemicals Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Decipher Labs Ltd is ₹ 8 as of 04 May 11:07 . The P/E Ratio of Decipher Labs Ltd changed from 24.1 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Decipher Labs Ltd changed from ₹ 33.78 crore on March 2021 to ₹ 10.62 crore on March 2025 . This represents a CAGR of -20.66% over 5 yearsThe Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Decipher Labs Ltd for the Dec '25 is ₹ 3.23 crore as compare to the Sep '25 revenue of ₹ 4.33 crore. This represent the decline of -25.4% The revenue of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Decipher Labs Ltd for the Dec '25 is ₹ -0.41 crore as compare to the Sep '25 ebitda of ₹ 0.14 crore. This represent the decline of -392% The ebitda of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Decipher Labs Ltd changed from ₹ 0.95 crore to ₹ -0.54 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Decipher Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Decipher Labs Ltd

Decipher Labs Ltd. (formerly known as Combat Drugs Ltd) was incorporated as a Private Limited Company in September, 1986 and was converted into a Public Limited Company in Jun.'92.
The company was promoted by Suchit Mohan Lal and Ajay Karan. The Company is a professionally managed, well established, diversified Public Limited Company, engaged in the Manufacture & Marketing of Pharmaceuticals and allied products and services and providing Services and key Solutions in Information Technology Industry.
Since inception, the Company has been manufacturing & marketing its branded formulations and custom manufacturing for various companies besides supplies of various Bulk drugs, chemicals and Finished Formulations.
During the years of operations, it has garnered a reputation as a quality provider in the Pharmaceutical industry and the Products marketed by the Company have been well accepted by the Trade and Medical Fraternity across India.

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Limited was initially incorporated as 'Krebs Biochemicals Limited' in 1991.
The name of the Company was changed from Krebs Biochemicals Limited to Krebs Biochemicals & Industries Limited effected from November 21, 2003.
Promoted by R T Ravi, Company engages in manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry.
Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA.

FAQs for the comparison of Decipher Labs Ltd and Krebs Biochemicals & Industries Ltd

Which company has a larger market capitalization, Decipher Labs Ltd or Krebs Biochemicals & Industries Ltd?

Market cap of Decipher Labs Ltd is 8 Cr while Market cap of Krebs Biochemicals & Industries Ltd is 129 Cr

What are the key factors driving the stock performance of Decipher Labs Ltd and Krebs Biochemicals & Industries Ltd?

The stock performance of Decipher Labs Ltd and Krebs Biochemicals & Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Decipher Labs Ltd and Krebs Biochemicals & Industries Ltd?

As of May 4, 2026, the Decipher Labs Ltd stock price is INR ₹8.0. On the other hand, Krebs Biochemicals & Industries Ltd stock price is INR ₹60.12.

How do dividend payouts of Decipher Labs Ltd and Krebs Biochemicals & Industries Ltd compare?

To compare the dividend payouts of Decipher Labs Ltd and Krebs Biochemicals & Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.